Abiomed (ABMD) Halted Ahead of FDA Meeting on Blood Pumps
- All Eyes on Apple (AAPL) Into Q2 Print; FX, Capital Return Seen as Wildcards
- Unusual 11 Mid-Day Movers 4/27: (SYMX) (CANF) (GLBS) Higher; (CLDN) (AKRX) (SILC) Lower
- Applied Materials (AMAT), Tokyo Electron Terminate Merger
- Mylan (MYL) Rejects Unsolicited Teva (TEVA) Proposal
- Pre-Open Stock Movers 04/27: (SYMX) (WIN) (PWRD) (IGTE) Higher; (CLDN) (AKRX) (AMAT) Lower (more...)
Abiomed, Inc. (NASDAQ: ABMD) halted ahead of FDA advisory committee meeting over nonroller-type cardiopulmonary bypass blood pumps.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OncoGenex Pharma (OGXI) Will Regain Custirsen Rights from Teva (TEVA)
- Catyalyst Pharmaceutical (CPRX) Slammed as Promising Competing Drug Highlighted
- MannKind (MNKD) Will Begin Manufacturing of 12 Unit Cartridge Strength of AFREZZA
Create E-mail Alert Related CategoriesFDA, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!